Peanut Oral Immunotherapy Study: Safety Efficacy and Discovery (POISED)

AllerGenis Begins Testing Patient Samples for Peanut Allergy Using Proprietary Epitope...

News Wire ~ 3rd Party Press Release - 2020/06/24

VeriMAP Peanut Diagnostic has a 93% concordance with food challenge results providing a diagnosis with greater certainty.

Study: Few People with Peanut Allergy Tolerate Peanut after Stopping OIT

News Wire ~ 3rd Party Press Release - 2019/09/16

Continuing with a modest dose confers more protection, NIH-funded study finds.

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: Peanut Oral Immunotherapy Study: Safety Efficacy and Discovery (POISED)

AllerGenis Begins Testing Patient Samples for Peanut Allergy Using Proprietary Epitope...

Study: Few People with Peanut Allergy Tolerate Peanut after Stopping OIT